Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV000680142 | SCV000807587 | pathogenic | Xeroderma pigmentosum, group C | 2017-09-01 | criteria provided, single submitter | clinical testing | This splice site variant is categorized as deleterious according to ACMG guidelines (PMID:18414213) and was found once in our laboratory homozygous in a 15-year-old female with cafe-au-lait spots, freckling, and photosensitivity. |
Revvity Omics, |
RCV000680142 | SCV002017953 | likely pathogenic | Xeroderma pigmentosum, group C | 2021-05-06 | criteria provided, single submitter | clinical testing | |
Gene |
RCV003314635 | SCV004014153 | likely pathogenic | not provided | 2023-06-21 | criteria provided, single submitter | clinical testing | Canonical splice site variant predicted to result in an in-frame loss of the adjacent exon in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25326635, 32359129, 27535533) |
Biochemical Molecular Genetic Laboratory, |
RCV000680142 | SCV001132881 | likely pathogenic | Xeroderma pigmentosum, group C | 2019-01-29 | no assertion criteria provided | clinical testing |